RegenScientific and Soluvos Medical enter into distribution agreement for Renú ® Voice in the United Kingdom, Ireland, Benelux, Scandinavia, Germany and Austria

The companies have entered into an exclusive distribution agreement forRegenScientific’s ENT products, indicated forVocal Fold Insufficiency, in the United Kingdom, Ireland, The Netherlands, Belgium, Luxembourg, Denmark, Sweden, Finland, Norway and Iceland. Soluvos Medical also has non-exclusive rights in Germany and Austria.

RegenScientific and Soluvos Medical announced today that the companies have entered into an exclusive distribution agreement for Renú® Voice and Renú® Gel in the United Kingdom, Ireland, The Netherlands, Belgium, Luxembourg, Denmark, Sweden, Finland, Norway and Iceland. Soluvos Medical will also serve as the temporary distributor to physicians in other European countries where RegenScientific has regulatory clearance to market its products. RegenScientific secured the CE-mark on its Renú® Voice and Renú® Dermal Filler in December 2015, and on its Transoral needle in September 2016. The company is currently in the process of applying for the CE-mark on its Renú® Gel product.

RegenScientific launched Renú® Gel and Renú® Voice in the United States in 2015 after receiving FDA-clearance for Vocal Fold Insufficiency which is a condition often found in patients with voice and swallowing disorders. RegenScientific currently co-markets these products in the United States with Boston Medical Products, Inc.

“We launched Renú® Voice at the 2016 European Laryngological Society Congress in Genoa, Italy. We received great interest from laryngologists at the congress, and we are excited to team up with Soluvos Medical to expand the availability of our cost-effective vocal fold injection augmentation products to physicians in Europe,” said Mr. Charles Milo, MBA, Chief Business Officer at RegenScientific, and he added, “The Managing Directors of Soluvos Medical – Ms. Rose Henrichs, MBA, and Mr. Jeroen Doomernik – have extensive business experience with laryngology products and a successful history of collaboration with laryngologists in Europe.”

Mrs. Rose Henrichs, MBA, Managing Director at Soluvos Medical said, “We are enthusiastic about our distribution agreement with RegenScientific,” and she continued, “Renú® Voice is pivotal in our product offering and we’re eager to add Renú® Gel when RegenScientific secures the CE-mark for that product.”

Mr. Jeroen Doomernik, Managing Director at Soluvos Medical said, “Soluvos Medical will exhibit at Cutting Edge Laryngology in London, UK, 5-7 October 2016, Endoscopy Course at the University of Nijmegen, The Netherlands, 24 November 2016, Winter Days of Laryngology in Crans Montana, Switzerland, 11-14 January 2017, and at the ELS workshop in Leipzig, Germany, 27-28 January 2017. We are looking forward to introduce physicians to the product portfolio of RegenScientific.”